Article metrics
PDF
Other content recommended for you
- On the personal utility of Alzheimer’s disease-related biomarker testing in the research context
- Personal utility in genomic testing: is there such a thing?
- Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population
- CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer’s disease: a meta-analysis of 51 studies
- Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia
- New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist
- CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease
- Impact of dementia on informal care: a systematic review of family caregivers’ perceptions
- Resilience of family caregivers of people with dementia in South Korea: protocol for a scoping review
- Destruction of White Matter Integrity in Patients With Mild Cognitive Impairment and Alzheimer Disease